Kinetics of recombinant adeno-associated virus-mediated gene transfer

Journal of Virology

Volumn 74, Issue 8, 2000, Pages 3555-3565

  Malik, Ajay K ^a   Monahan, Paul E ^b   Allen, David L ^a   Chen, Bing Guan ^a   Samulski, R Jude ^b   Kurachi, Kotoku ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BLOOD CLOTTING FACTOR 9; CREATINE KINASE; DNA;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPISOME; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS RECOMBINANT;

BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL DIVISION; CELLS, CULTURED; DEPENDOVIRUS; DNA; DNA, SINGLE-STRANDED; DNA, VIRAL; FACTOR IX; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; KINETICS; MUSCLE, SKELETAL; TRANSFECTION; TRANSGENES; VIRION;

EID: 0034108732     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.8.3555-3565.2000     Document Type: Article

References (77)

1. Addison, C. L., M. Hilt, D. Kunsken, and F. L. Graham. 1997. Comparison of the human versus murine cytomegalovirus immediate early gene promot-ers for transgene expression by adenoviral vectors. J. Gen. Virol. 78:1653-1661.
2. Afione, S, A., C. K. Conrad, W. G. Kearns, S. Chunduru, R. Adams, T. C. Reynolds, W. B. Guggino, G. R. Cutting, B. J. Carter, and T. R. Flotte. 1996. In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70:3235-3241.
3. Afione, S. A., J. Wang, S. Walsh. W. B. Guggino, and T. R. Flotte. 1999. Delayed expression of adeno-associated virus vector DNA. Intervirology 42:213-220.
4. Alexander, I. E., D. W. Russell, and A. D. Miller. 1997. Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results. Hum. Gene Ther. 8:1911-1920.
5. Atchinson, R. W., B. C. Casto, and W. M. Hammon. 1965. Adenovirus-associated defective virus particles. Science 149:754-756.
6. Barr, E., and J. M. Leiden. 1991. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254:1507-1509.
7. Baskar. J. F., P. P. Smith, G. S. Ciment, S. Hoffmann, C. Tucker, D. J. Tenney, A. M. Colberg-Poley, J. A. Nelson, and P. Ghazal. 1996. Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J. Virol. 70:3215-3226.
8. Baskar, J. F., P. P. Smith, G. Nilaver, R. A. Jupp, S. Hoffmann, N. J. Peffer, D. J. Tenney, A. M. Colberg-Poley, P. Ghazal, and J. A. Nelson. 1996. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:3207-3214.
9. Berns, K. I., and J. A. Rose. 1970. Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J. Virol. 5:693-699.
10. Blacklow, N. R., M. D. Hoggan, A. Z. Kapikian, J. B. Austin, and W. P. Rowe. 1968. Epidemiology of adenovirus-associated virus infection in a nursery population. Am. J. Epidemiol. 88:368-378.
11. Blacklow, N. R., M. D. Hoggan, and W. P. Rowe. 1968. Serologie evidence for human infection with adenovirus-associated viruses. J. Natl. Cancer Inst. 40:19-27.
12. Buller, R. M., J. E. Janik, E. D. Sebring, and J. A. Rose. 1981. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J. Virol. 40:241-247.
13. Cheung, A. K. M., M. D. Hoggan, W. W. Hauswirth, and K. I. Berns. 1980. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 33:739-748.
14. Cheung, W.-F., J. van den Born, K. Kühn, L. Kjellén, B. G. Hudson, and D. W. Stafford. 1996. Identification of the endothelial cell binding site for factor IX. Proc. Nail. Acad. Sci. USA 93:11068-11073.
15. Clark, K. R., T. J. Sferra, and P. R. Johnson. 1997. Recombinant adenoassociated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8:659-669.
16. Dai, Y., M. Roman, R. K. Naviaux, and I. M. Verma. 1992. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89:10892-10895.
17. Davie, E. W., and O. D. Ratnoff. 1964. Waterfall sequence for intrinsic blood clotting. Science 145:1310-1312.
18. Dhawan. J., L. C. Pan, G. K. Pavlath, M. A. Travis, A. M. Lanctot, and H. M. Blau. 1991. Systemic delivery of human growth hormone by injection of genetically engineered myohlasts. Science 254:1509-1512.
19. Duan, D., P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K. J. Fisher, and J. F. Engelhardt. 1998. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72:8568-8577.
20. During, M. J., R. Xu, D. Young, M. G. Kaplitt, R. S. Sherwin, and P. Leone. 1998. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat. Med. 4:1131-1135.
21. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
22. Fisher, K. J., G.-P. Gao, M. D. Weilzman, R. DeMatteo. J. F. Burda. and J. M. Wilson. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:520-532.
23. Fisher, K. J., K. Jooss, J. Alston, Y. Yang, S. E. Haecker, K. High, R. Pathak, S. E. Raper, and J. M. Wilson. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:306-312.
24. Flotte, T. R., S. A. Afione, R. Solow, M. L. Drumm, D. Markakis. W. B. Guggino, P. L. Zeitlin, and B. J. Carter. 1993. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268:3781-3790.
25. Flotte, T. R., S. A. Afione, and P. L. Zeitlin. 1994. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11:517-521.
26. Hargrove, P. W., E. F. Vanin, G. J. Kurtzman, and A. W. Nienhuis. 1997. High-level globin gene expression mediated by a recombinant adeno-asso-ciated virus genome that contains the 3' gamma globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 89:2167-2175.
27. Herzog, R. W., J. N. Hagstrom, S.-H. Kung, S. J. Tai, J. M. Wilson, K. J. Fisher, and K. A. High. 1997. Stable gene transfer and expression of human blood coagulation factor IX alter intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94:5804-5809.
28. Herzog, R. W., E. Y. Yang, L. B. Couto, J. N. Hagstrom, D. Elwell, P. A. Fields, M. Burton, D. A. Bellinger, M. S. Read, K. M, Brinkhous, G. M. Podsakoff, T. C. Nichols, G. J. Kurtzman, and K. A. High. 1999. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector Nat. Med. 5:56-63.
29. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
30. Hoggan, M. D., N. R. Blacklow, and W. P. Rowe. 1966. Studies of small DNA viruses found in various adenovirus preparations: physical, biological and immunological characteristics. Proc. Natl. Acad. Sci. USA 55:1467-1474.
31. Jooss, K., Y. Yang, K. J. Fisher, and J. M. Wilson. 1998. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72:4212-1223.
32. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
33. Kearns, W. G., S. A. Afione, S. B. Fulmer, M. G. Pang, D. Erikson, M. Egan, M. J. Landrum, T. R. Flotte, and G. R. Cutting. 1996. Recombinant adenoassociated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3:748-755.
34. Kessler, P. D., G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne. 1996 Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93:14082-14087.
35. Koeberl, D. D., I. E. Alexander, C. L. Halbert, D. W. Russell, and A. D. Miller. 1997. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 94:1426-1431.
36. Kotin, R. M., M. Siniscalco, R. J. Samulski, X. Zhu, L. Hunter, C. A. Laughlin, S. McLaughlin, N. Muzyczka, M. Rocchi. and K. I. Berns. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87:2211-2215.
37. Karachi, K., S. Kurachi, M. Furukawa, and S.-N. Yao. 1993. Biology of factor IX. Blood Coagul. Fibrinolysis 4:953-974.
38. Kurachi, S., Y. Hitomi, M. Furukawa, and K. Kurachi. 1995. Role of intron I in expression of the human factor IX gene. J. Biol. Chem. 270:5276-5281.
39. Li, J., R. J. Samulski, and X. Xiao. 1997. Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71:5236-5243.
40. Linden, R. M., E. Wincour, and K. I. Berns. 1996. The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA 93:7966-7972.
41. Macfarlane, R. G. 1964. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202:498-499.
42. Malik, A. K., and S. K. Weller. 1996. Use of transdominant mutants of the origin binding protein (UL9) of herpes simplex virus type-1 to define functional domains. J. Virol. 70:7859-7866.
43. McLaughlin. S. K., P. Collis, P. L. Hermonat, and N. Muzyczka. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62:1963-1973.
44. Miao, C. H., R. O. Snyder, D. B. Schowalter, G. A. Patijn, B. Donahue, B. Winther, and M. A. Kay. 1998. The kinetics of rAAV integration in the liver. Nat. Genet. 19:13-14.
45. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
46. Monahan, P. E., J. Tazelaar, X. Xiao, T. C. Nichols, D. A. Bellinger, M. S. Read, C. E. Walsh, and R. J. Samulski. 1998. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. 5:40-49.
47. Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-129.
48. Nakai, H., Y. Iwaki, M. A. Kay, and L. B. Couto. 1999. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 73:5438-5447.
49. Philip, R., E. Brunette, L. Kilinski, D. Murugesh, M. A. McNally, K. Ucar, J. Rosenblatt, T. B. Okarma, and J. S. Lebkowski. 1994. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell. Biol. 14:2411-2418.
50. Pieroni, L., C. Fipaldini, A. Monciotti. D. Cimini, A. Sgura, E. Fattori, O. Epifano, R. Cortese, F. Palombo, and N. La Monica. 1998. Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 249:249-259.
51. Ponnazhagan, S., D. Erikson, W. G. Kearns, S. Z. Zhou, P. Nahreini, X.-S. Wang, and A. Srivastava. 1997. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8:275-284.
52. Qing, K., C. Mah, J. Hansen, S. Zhou, V. Dwarki, and A. Srivastava. 1999. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:71-77.
53. Rivadeneira, E. D., N. C. Popescu, D. B. Zimonjic, G. S. Cheng, P. J. Nelson, M. D. Ross, J. A. DiPaolo, and M. E. Klotman. 1998. Sites of recombinant adeno-associated virus integration. Int. J. Oncol. 12:805-810.
54. Russell, D. W., and M. A. Kay. 1999. Adeno-associated virus vectors and hematology. Blood. 94:864-874.
55. Rutledge, E. A., and D. W. Russell. 1997. Adeno-associated virus vector integration junctions. J. Virol. 71:8429-8436.
56. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
57. Samulski, R. J., L. S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
58. Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950.
59. Shering, A. F., D. Bain, K. Stewart, A. L. Epstein, M. G. Castro, G. W. G. Wilkinson, and P. R. Lowenstein. 1997. Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. J. Gen. Virol. 78:445-459.
60. Snyder, R. O., C. H. Miao, G. A. Patijn, S. K. Spratt, O. Danos, D. Nagy, A. M. Gown, B. Winther, L. Meuse, L. K. Cohen, A. R. Thompson, and M. A. Kay. 1997. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet 16:270-276.
61. Snyder, R. O., S. K. Spratt, C. Lagarde, D. Bohl, B. Kasper, B. Sloan, L. K. Cohen, and O. Danos. 1997. Efficient and stable adeno-associated virusmediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8:1891-1900.
62. Summerford, C., J. S. Bartlett, and R. J. Samulski. 1999. αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5:78-82.
63. Summerford, C., and R. J. Samulski. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
64. Surosky, R. T., M. Urabe, S. G. Godwin. S. A. McQuiston, G. J. Kurtzman, K. Ozawa, and G. Natsoulis. 1997. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71:7951-7959.
65. Tenenbaum, L., M. Hamdane, M. Pouzet, B. Avalosse, A. Stathopoulos, F. Jurysta, C. Rosenbaum, C. O. Hanemann, M. Levivier, and T. Velu. 1999. Cellular contaminants of adeno-associated virus vector stocks can enhance transduction. Gene Ther. 6:1045-1053.
66. Vieweg, J., D. Boczkowski. K. M. Roberson. D. W. Edwards, M. Philip. R. Philip, T. Rudoll, C. Smith, C. Robertson, and E. Gilboa. 1995. Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer. Cancer Res. 55:2366-2372.
67. Vincent-Lacaze, N., R. O. Snyder, R. Gluzman, D. Bohl, C. Lagarde, and O. Danos. 1999. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J. Virol. 73:1949-1955.
68. Wang, J.-M., H. Zheng, M. Blaivas, and K. Kurachi. 1997. Persistent systemic production of human factor IX in mice hy skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels. Blood 90:1075-1082.
69. Wang, J.-M., H. Zheng, Y. Sugahara, J. Tan, S.-N. Yao, E. Olson, and K. Kurachi. 1996. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells. Hum. Gene Ther. 7:1743-1756.
70. Wu, P., M. I. Phillips, J. Bui, and E. F. Terwilliger. 1998. Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing ceil targets. J. Virol. 72:5919-5926.
71. Xiao, X., J. Li, and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
72. Xiao, X., J. Li, and R. J. Samulski. 1998. Production of high-tiler recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72:2224-2232.
73. Yao, S.-N., and K. Kurachi. 1992, Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl. Acad. Sci. USA 89:3357-3361.
74. Yao, S.-N., and K. Kurachi. 1993. Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells. J. Cell Sci. 105:957-963.
75. Yao, S.-N., and K. Kurachi. 1992. A simple treatment of serum for precise determination of recombinant factor IX in the culture media. BioTechniques 12:525-526.
76. Yao, S.-N., K. J. Smith, and K. Kurachi. 1994. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Ther. 1:99-107.
77. Zolotukhln, S., M. Potter, W. W. Hauswirth, J. Guy, and N. Muzyczka. 1996. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:4646-4654.